These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Antibody-mediated rejection and treatment in pediatric patients: one center's experience. Gulleroglu K, Baskin E, Bayrakci US, Turan M, Ozdemir BH, Moray G, Karakayali H, Haberal M. Exp Clin Transplant; 2013 Oct 27; 11(5):404-7. PubMed ID: 24128133 [Abstract] [Full Text] [Related]
8. Differential modulation of donor-specific antibodies after B-cell depleting therapies to cure chronic antibody mediated rejection. Touzot M, Couvrat-Desvergnes G, Castagnet S, Cesbron A, Renaudin K, Cantarovich D, Giral M. Transplantation; 2015 Jan 27; 99(1):63-8. PubMed ID: 25029384 [Abstract] [Full Text] [Related]
9. Significance of low-level DSA detected by solid-phase assay in association with acute and chronic antibody-mediated rejection. Hirai T, Kohei N, Omoto K, Ishida H, Tanabe K. Transpl Int; 2012 Sep 27; 25(9):925-34. PubMed ID: 22764746 [Abstract] [Full Text] [Related]
10. The influence of bortezomib on donor specific antibody reduction in patients with antibody mediated rejection. Hardinger KL, Murillo D. Clin Transpl; 2011 Sep 27; ():401-8. PubMed ID: 22755438 [Abstract] [Full Text] [Related]
18. Durable renal response after combination of bortezomib, corticosteroids, rituximab, and plasmapheresis for late antibody-mediated renal transplant rejection . Ding Y, Francis J, Gautam A, Pelletier L, Sanchorawala V, Quillen K. Clin Nephrol; 2018 Apr 27; 89(4):252-259. PubMed ID: 29208204 [Abstract] [Full Text] [Related]
20. A refractory case of subclinical antibody-mediated rejection due to anti-HLA-DQ antibody in a kidney transplant patient. Fujimoto T, Nakada Y, Yamamoto I, Kobayashi A, Tanno Y, Yamada H, Miki J, Ohkido I, Tsuboi N, Yamamoto H, Yokoo T. Nephrology (Carlton); 2015 Jul 27; 20 Suppl 2():81-5. PubMed ID: 26031594 [Abstract] [Full Text] [Related] Page: [Next] [New Search]